Royal Capital Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-429
| Closed | -$201K | – | 98 |
|
|
2024
Q2 | $201K | Buy |
+429
| New | +$201K | 0.15% | 88 |
|
|
2024
Q1 | – | Sell |
-1,002
| Closed | -$408K | – | 100 |
|
|
2023
Q4 | $408K | Sell |
1,002
-15
| -1% | -$6.1K | 0.35% | 53 |
|
|
2023
Q3 | $354K | Sell |
1,017
-38
| -4% | -$13.2K | 0.34% | 56 |
|
|
2023
Q2 | $371K | Hold |
1,055
| – | – | 0.35% | 56 |
|
|
2023
Q1 | $332K | Sell |
1,055
-24
| -2% | -$7.55K | 0.33% | 63 |
|
|
2022
Q4 | $312K | Hold |
1,079
| – | – | 0.33% | 62 |
|
|
2022
Q3 | $312K | Hold |
1,079
| – | – | 0.36% | 62 |
|
|
2022
Q2 | $304K | Hold |
1,079
| – | – | 0.33% | 67 |
|
|
2022
Q1 | $282K | Sell |
1,079
-6
| -0.6% | -$1.57K | 0.28% | 79 |
|
|
2021
Q4 | $238K | Buy |
+1,085
| New | +$238K | 0.23% | 88 |
|